Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8213 |
Intermediate Similarity |
NPD7998 |
Clinical (unspecified phase) |
0.8155 |
Intermediate Similarity |
NPD8493 |
Clinical (unspecified phase) |
0.8048 |
Intermediate Similarity |
NPD7594 |
Clinical (unspecified phase) |
0.8038 |
Intermediate Similarity |
NPD6204 |
Clinical (unspecified phase) |
0.7952 |
Intermediate Similarity |
NPD7809 |
Clinical (unspecified phase) |
0.7915 |
Intermediate Similarity |
NPD8013 |
Clinical (unspecified phase) |
0.7913 |
Intermediate Similarity |
NPD7817 |
Phase 1 |
0.7897 |
Intermediate Similarity |
NPD8000 |
Clinical (unspecified phase) |
0.7897 |
Intermediate Similarity |
NPD8406 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD5901 |
Discontinued |
0.7882 |
Intermediate Similarity |
NPD7944 |
Discontinued |
0.7882 |
Intermediate Similarity |
NPD7619 |
Phase 3 |
0.7882 |
Intermediate Similarity |
NPD7618 |
Phase 3 |
0.7822 |
Intermediate Similarity |
NPD6180 |
Clinical (unspecified phase) |
0.781 |
Intermediate Similarity |
NPD6838 |
Clinical (unspecified phase) |
0.7805 |
Intermediate Similarity |
NPD6664 |
Approved |
0.7804 |
Intermediate Similarity |
NPD8112 |
Clinical (unspecified phase) |
0.7783 |
Intermediate Similarity |
NPD4922 |
Phase 2 |
0.7761 |
Intermediate Similarity |
NPD3961 |
Discontinued |
0.774 |
Intermediate Similarity |
NPD7903 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD6164 |
Phase 2 |
0.7738 |
Intermediate Similarity |
NPD6165 |
Phase 2 |
0.7729 |
Intermediate Similarity |
NPD7621 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD6595 |
Phase 3 |
0.7714 |
Intermediate Similarity |
NPD8272 |
Phase 2 |
0.7704 |
Intermediate Similarity |
NPD482 |
Approved |
0.7664 |
Intermediate Similarity |
NPD7470 |
Discontinued |
0.765 |
Intermediate Similarity |
NPD2094 |
Phase 2 |
0.765 |
Intermediate Similarity |
NPD5728 |
Clinical (unspecified phase) |
0.765 |
Intermediate Similarity |
NPD2095 |
Phase 2 |
0.765 |
Intermediate Similarity |
NPD2092 |
Phase 2 |
0.7639 |
Intermediate Similarity |
NPD7971 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD7970 |
Approved |
0.763 |
Intermediate Similarity |
NPD8115 |
Approved |
0.763 |
Intermediate Similarity |
NPD8114 |
Approved |
0.7628 |
Intermediate Similarity |
NPD8093 |
Discontinued |
0.7624 |
Intermediate Similarity |
NPD4426 |
Clinical (unspecified phase) |
0.7615 |
Intermediate Similarity |
NPD8405 |
Clinical (unspecified phase) |
0.7612 |
Intermediate Similarity |
NPD2091 |
Phase 2 |
0.7612 |
Intermediate Similarity |
NPD2096 |
Phase 2 |
0.7583 |
Intermediate Similarity |
NPD2121 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD749 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD7712 |
Clinical (unspecified phase) |
0.7525 |
Intermediate Similarity |
NPD7564 |
Discontinued |
0.7525 |
Intermediate Similarity |
NPD4128 |
Approved |
0.7524 |
Intermediate Similarity |
NPD8248 |
Clinical (unspecified phase) |
0.7523 |
Intermediate Similarity |
NPD2442 |
Approved |
0.7523 |
Intermediate Similarity |
NPD6752 |
Phase 1 |
0.7523 |
Intermediate Similarity |
NPD2443 |
Approved |
0.7523 |
Intermediate Similarity |
NPD6753 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD4614 |
Clinical (unspecified phase) |
0.7488 |
Intermediate Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD4075 |
Phase 2 |
0.7475 |
Intermediate Similarity |
NPD750 |
Phase 2 |
0.7465 |
Intermediate Similarity |
NPD5426 |
Phase 3 |
0.7462 |
Intermediate Similarity |
NPD4184 |
Clinical (unspecified phase) |
0.7454 |
Intermediate Similarity |
NPD4051 |
Discontinued |
0.745 |
Intermediate Similarity |
NPD6203 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD7947 |
Clinical (unspecified phase) |
0.7431 |
Intermediate Similarity |
NPD8094 |
Discontinued |
0.743 |
Intermediate Similarity |
NPD7957 |
Phase 1 |
0.743 |
Intermediate Similarity |
NPD7958 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD4863 |
Approved |
0.7416 |
Intermediate Similarity |
NPD7818 |
Clinical (unspecified phase) |
0.7416 |
Intermediate Similarity |
NPD4848 |
Phase 1 |
0.7415 |
Intermediate Similarity |
NPD8431 |
Approved |
0.7415 |
Intermediate Similarity |
NPD4988 |
Discontinued |
0.7413 |
Intermediate Similarity |
NPD4076 |
Approved |
0.7413 |
Intermediate Similarity |
NPD4079 |
Approved |
0.7406 |
Intermediate Similarity |
NPD7727 |
Phase 2 |
0.7378 |
Intermediate Similarity |
NPD8289 |
Discontinued |
0.7364 |
Intermediate Similarity |
NPD3393 |
Approved |
0.7364 |
Intermediate Similarity |
NPD3389 |
Approved |
0.7364 |
Intermediate Similarity |
NPD3394 |
Approved |
0.7363 |
Intermediate Similarity |
NPD3506 |
Approved |
0.7363 |
Intermediate Similarity |
NPD3505 |
Approved |
0.7361 |
Intermediate Similarity |
NPD2509 |
Approved |
0.7361 |
Intermediate Similarity |
NPD2510 |
Approved |
0.7353 |
Intermediate Similarity |
NPD3607 |
Clinical (unspecified phase) |
0.735 |
Intermediate Similarity |
NPD5065 |
Approved |
0.7349 |
Intermediate Similarity |
NPD5489 |
Phase 1 |
0.7349 |
Intermediate Similarity |
NPD2008 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD5491 |
Phase 3 |
0.7342 |
Intermediate Similarity |
NPD5199 |
Approved |
0.7342 |
Intermediate Similarity |
NPD5198 |
Approved |
0.7336 |
Intermediate Similarity |
NPD8072 |
Approved |
0.7336 |
Intermediate Similarity |
NPD6176 |
Phase 1 |
0.733 |
Intermediate Similarity |
NPD6141 |
Clinical (unspecified phase) |
0.7327 |
Intermediate Similarity |
NPD2408 |
Discontinued |
0.7327 |
Intermediate Similarity |
NPD3968 |
Approved |
0.7324 |
Intermediate Similarity |
NPD5017 |
Discontinued |
0.7323 |
Intermediate Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD3411 |
Phase 2 |
0.7315 |
Intermediate Similarity |
NPD3410 |
Approved |
0.7313 |
Intermediate Similarity |
NPD7780 |
Approved |
0.7313 |
Intermediate Similarity |
NPD7781 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5592 |
Clinical (unspecified phase) |
0.7306 |
Intermediate Similarity |
NPD2411 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7603 |
Discontinued |
0.7295 |
Intermediate Similarity |
NPD7175 |
Phase 1 |
0.7295 |
Intermediate Similarity |
NPD8110 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD6173 |
Approved |
0.7281 |
Intermediate Similarity |
NPD7665 |
Phase 2 |
0.7281 |
Intermediate Similarity |
NPD7666 |
Phase 3 |
0.7277 |
Intermediate Similarity |
NPD4181 |
Approved |
0.7269 |
Intermediate Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.7264 |
Intermediate Similarity |
NPD1982 |
Phase 1 |
0.7261 |
Intermediate Similarity |
NPD7790 |
Approved |
0.7261 |
Intermediate Similarity |
NPD7951 |
Approved |
0.7261 |
Intermediate Similarity |
NPD7791 |
Approved |
0.7261 |
Intermediate Similarity |
NPD7950 |
Approved |
0.7261 |
Intermediate Similarity |
NPD7789 |
Approved |
0.7261 |
Intermediate Similarity |
NPD7953 |
Approved |
0.7261 |
Intermediate Similarity |
NPD7952 |
Approved |
0.726 |
Intermediate Similarity |
NPD3915 |
Approved |
0.726 |
Intermediate Similarity |
NPD5475 |
Discontinued |
0.7251 |
Intermediate Similarity |
NPD6226 |
Phase 3 |
0.7248 |
Intermediate Similarity |
NPD5510 |
Approved |
0.7246 |
Intermediate Similarity |
NPD4948 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD3486 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD1506 |
Discontinued |
0.7232 |
Intermediate Similarity |
NPD6242 |
Discontinued |
0.7227 |
Intermediate Similarity |
NPD3917 |
Approved |
0.7227 |
Intermediate Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.7227 |
Intermediate Similarity |
NPD3918 |
Approved |
0.7227 |
Intermediate Similarity |
NPD3916 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD3947 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD6850 |
Phase 2 |
0.7212 |
Intermediate Similarity |
NPD6849 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD8073 |
Approved |
0.7204 |
Intermediate Similarity |
NPD7024 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD7232 |
Discontinued |
0.7198 |
Intermediate Similarity |
NPD5820 |
Clinical (unspecified phase) |
0.7196 |
Intermediate Similarity |
NPD4601 |
Approved |
0.7196 |
Intermediate Similarity |
NPD4600 |
Approved |
0.7195 |
Intermediate Similarity |
NPD8488 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD7730 |
Approved |
0.7193 |
Intermediate Similarity |
NPD7731 |
Approved |
0.7193 |
Intermediate Similarity |
NPD4845 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD5505 |
Discontinued |
0.7189 |
Intermediate Similarity |
NPD3967 |
Approved |
0.7189 |
Intermediate Similarity |
NPD7001 |
Phase 3 |
0.7181 |
Intermediate Similarity |
NPD7271 |
Approved |
0.7178 |
Intermediate Similarity |
NPD2928 |
Phase 2 |
0.7177 |
Intermediate Similarity |
NPD4499 |
Approved |
0.7175 |
Intermediate Similarity |
NPD7823 |
Clinical (unspecified phase) |
0.7156 |
Intermediate Similarity |
NPD8322 |
Phase 2 |
0.715 |
Intermediate Similarity |
NPD6999 |
Discontinued |
0.715 |
Intermediate Similarity |
NPD7000 |
Clinical (unspecified phase) |
0.715 |
Intermediate Similarity |
NPD5555 |
Phase 1 |
0.7149 |
Intermediate Similarity |
NPD7657 |
Approved |
0.7149 |
Intermediate Similarity |
NPD7656 |
Approved |
0.7149 |
Intermediate Similarity |
NPD7195 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6987 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD3960 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6288 |
Clinical (unspecified phase) |
0.7136 |
Intermediate Similarity |
NPD7825 |
Clinical (unspecified phase) |
0.7136 |
Intermediate Similarity |
NPD5446 |
Phase 2 |
0.713 |
Intermediate Similarity |
NPD3353 |
Approved |
0.713 |
Intermediate Similarity |
NPD6268 |
Phase 1 |
0.713 |
Intermediate Similarity |
NPD6269 |
Clinical (unspecified phase) |
0.713 |
Intermediate Similarity |
NPD7824 |
Approved |
0.713 |
Intermediate Similarity |
NPD7187 |
Phase 2 |
0.7122 |
Intermediate Similarity |
NPD5473 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD2823 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD5809 |
Phase 3 |
0.7115 |
Intermediate Similarity |
NPD7026 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD4558 |
Phase 2 |
0.7112 |
Intermediate Similarity |
NPD5040 |
Clinical (unspecified phase) |
0.7111 |
Intermediate Similarity |
NPD7404 |
Approved |
0.7108 |
Intermediate Similarity |
NPD2144 |
Approved |
0.7098 |
Intermediate Similarity |
NPD4374 |
Clinical (unspecified phase) |
0.7098 |
Intermediate Similarity |
NPD2787 |
Clinical (unspecified phase) |
0.7098 |
Intermediate Similarity |
NPD2813 |
Phase 3 |
0.7098 |
Intermediate Similarity |
NPD2812 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD7027 |
Phase 3 |
0.7089 |
Intermediate Similarity |
NPD7061 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD6449 |
Clinical (unspecified phase) |
0.7087 |
Intermediate Similarity |
NPD3178 |
Discontinued |
0.7085 |
Intermediate Similarity |
NPD8242 |
Clinical (unspecified phase) |
0.708 |
Intermediate Similarity |
NPD6210 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD5575 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD8386 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD7308 |
Discontinued |
0.7069 |
Intermediate Similarity |
NPD8119 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD6470 |
Phase 3 |
0.7067 |
Intermediate Similarity |
NPD6578 |
Clinical (unspecified phase) |
0.7064 |
Intermediate Similarity |
NPD7207 |
Approved |
0.7064 |
Intermediate Similarity |
NPD7209 |
Approved |
0.7064 |
Intermediate Similarity |
NPD7208 |
Approved |
0.7062 |
Intermediate Similarity |
NPD5042 |
Phase 1 |
0.7062 |
Intermediate Similarity |
NPD2336 |
Approved |
0.7056 |
Intermediate Similarity |
NPD7948 |
Phase 1 |
0.7053 |
Intermediate Similarity |
NPD3319 |
Phase 1 |
0.7053 |
Intermediate Similarity |
NPD3320 |
Approved |
0.7053 |
Intermediate Similarity |
NPD3318 |
Approved |
0.7046 |
Intermediate Similarity |
NPD3914 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD6486 |
Approved |
0.7045
|
Intermediate Similarity |
NPD6487 |
Approved |